Recently, an adverse outcome pathway (AOP) was proposed for breast-cancer related cell death, with AhR as the molecular initiating event (MIE), decreased apoptosis and increased motility, inflammation, and endothelial migration as cellular key events (KE) [29]. The gene discussed is AHR; the disease is breast carcinoma.